|
|
|
Volumn 20, Issue 8-12, 2006, Pages 1-4
|
|
Something new under the sun. Maraviroc poised for approval.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4,4 DIFLUORO N ((1S) 3 (EXO 3 (3 ISOPROPYL 5 METHYL 4H 1,2,4 TRIAZOL 4 YL) 8 AZABICYCLO(3.2.1)OCT 8 YL) 1 PHENYLPROPYL)CYCLOHEXANECARBOXAMIDE;
4,4-DIFLUORO-N-((1S)-3-(EXO-3-(3-ISOPROPYL-5-METHYL-4H-1,2,4-TRIAZOL-4-YL)-8-AZABICYCLO(3.2.1)OCT-8-YL)-1-PHENYLPROPYL)CYCLOHEXANECARBOXAMIDE;
CHEMOKINE RECEPTOR CCR5;
CYCLOHEXANE DERIVATIVE;
HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR;
TRIAZOLE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL;
ARTICLE;
CD4 LYMPHOCYTE COUNT;
DRUG ANTAGONISM;
DRUG APPROVAL;
GENETICS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MOUSE;
MOUSE MUTANT;
PHYSIOLOGY;
ANIMALS;
CD4 LYMPHOCYTE COUNT;
CYCLOHEXANES;
DRUG APPROVAL;
HIV FUSION INHIBITORS;
HIV INFECTIONS;
HUMANS;
MICE;
MICE, KNOCKOUT;
RECEPTORS, CCR5;
TRIAZOLES;
|
|
EID: 34250671968
PISSN: 10771824
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
